Therapy News and Research

RSS

HIV-infected adults with MDD more likely to experience heart attack, study shows

Among more than 26,000 human immunodeficiency virus (HIV)-infected adults, those with major depressive disorder (MDD) were more likely to experience a heart attack than those without MDD, according to a study published online by JAMA Cardiology.

24 Aug 2016

New research discovers how opposite-sex hormonal therapy influences the brain

Women and men often show marked differences as regards mental illnesses. In order to learn more about this phenomenon, a project supported by the Austrian Science Fund FWF explored how opposite-sex hormonal therapy applied to transgender individuals influences the brain.

24 Aug 2016

ISCT announces reasons for opposing current version of REGROW Act on cell therapies

The International Society for Cellular Therapy, the global society of clinicians, researchers, regulatory specialists, technologists, and industry partners dedicated to the translation of cellular therapy into safe and effective therapies to improve patients’ lives, today announces its reasons for opposition to the current version of the REGROW Act - the US government’s legislative efforts to promote faster patient access to effective new cellular therapies.

24 Aug 2016

Acupuncture may be viable option to manage pain in children with complex medical conditions

It appears that acupuncture may be a viable option for pain management when it comes to pediatric patients who have complex medical conditions, according to new research published by Gillette Children's Specialty Healthcare in St. Paul, Minnesota.

24 Aug 2016

Transient dose of rapamycin in middle age can increase life expectancy, improve measures of healthy aging

Geroscience researchers studying the biology of aging briefly treated middle-aged mice with the drug rapamycin to gauge the long-term effects of short-term therapy on health and longevity.

24 Aug 2016

Scientists move a step closer to translating BubR1 protein's function into potential cancer therapy

In a paper published recently in the journal eLife, Mayo Clinic scientists take a step toward translating the protein BubR1's function into a potential therapy for cancer.

24 Aug 2016

MDI Biological Laboratory researchers receive patent for novel heart disease drug

The U.S. Patent and Trademark Office has announced that it will grant a patent to MDI Biological Laboratory scientists Voot P. Yin, Ph.D., and Kevin Strange, Ph.D., and their collaborator Michael Zasloff, M.D., Ph.D., for use of the small molecule MSI-1436 to stimulate the repair and regeneration of heart tissue damaged by injuries such as a heart attack.

23 Aug 2016

Novel scaffolds may open new avenues in stem and cancer cell manipulation

A discovery in the field of biomaterials may open new frontiers in stem and cancer cell manipulation and associated advanced therapy development.

23 Aug 2016

New drug target could help prevent opioid tolerance and addiction

Researchers have identified a brain mechanism that could be a drug target to help prevent tolerance and addiction to opioid pain medication, such as morphine, according to a study by Georgia State University and Emory University.

23 Aug 2016

Injecting omega-3 fatty acid reduces brain damage in neonatal mouse model of stroke

Researchers from Columbia University Medical Center found that omega-3 fatty acids reduced brain damage in a neonatal mouse model of stroke.

23 Aug 2016

Genekam develops first therapeutic molecule candidate for Zika viruses

GenekamBiotechnology AG, which developed the first test for Zika virus detection in January 2016, has developed as one of first company in the world the therapeutic molecule candidate for Zika viruses, which is likely to be the first potential candidate for Zika-virus therapy.

19 Aug 2016

$Vertebroplasty helps decrease acute pain in patients with osteoporotic fractures$

Vertebroplasty helps decrease acute pain in patients with osteoporotic fractures

Vertebroplasty is a safe and effective procedure to reduce acute pain and disability in patients who have experienced spinal fractures within a 6-week period, according to a new study published this week in The Lancet.

19 Aug 2016

Checkpoint inhibitor for treatment of NSCLC patients shows indication of added benefit

Nivolumab has been approved since April 2016 as a checkpoint inhibitor for the treatment of adults with locally advanced or metastatic nonsquamous non-small-cell lung cancer (NSCLC) who have already undergone chemotherapy.

19 Aug 2016

Added benefit of combination drug for HIV-infected patients not proven

The drug combination emtricitabine/tenofovir alafenamide is approved in combination with other antiviral agents for the treatment of adults and adolescents infected with human immunodeficiency virus type 1 (HIV-1).

19 Aug 2016

Smokers who switch to vaping may have fewer respiratory infections, study reveals

The majority of smokers who successfully switch to vaping say they have fewer respiratory infections, according to a study led by Queen Mary University of London.

19 Aug 2016

Added benefit of lung cancer drug not proven, says IQWiG

Afatinib (trade name: Giotrif) has been approved since April 2016 for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) of squamous histology who have already received chemotherapy.

19 Aug 2016

Added benefit not proven for orphan drug in treatment of adults with stomach cancer

Ramucirumab (trade name: Cyramza) is a monoclonal antibody, which blocks a receptor, reducing the growth of blood vessels and so reducing blood supply to the tumours.

19 Aug 2016

Added benefit still not proven for epilepsy drug

Brivaracetam (trade name: Briviact) has been approved since January 2016 as add-on therapy for adults and adolescents from 16 years of age with epileptic seizures.

19 Aug 2016

Penn researchers uncover strategy to reverse effects of dyskeratosis congenita

Dyskeratosis congenita, or DC, is a rare, inherited disease for which there are limited treatment options and no cure.

18 Aug 2016

Cell therapy product can accelerate brain remyelination in mice

Demyelinating diseases, such as multiple sclerosis and leukodystrophy, are characterized by damage to the protective myelin sheath that surrounds the axons of neurons.

18 Aug 2016

Therapy News and Research

HIV-infected adults with MDD more likely to experience heart attack, study shows

New research discovers how opposite-sex hormonal therapy influences the brain

ISCT announces reasons for opposing current version of REGROW Act on cell therapies

Acupuncture may be viable option to manage pain in children with complex medical conditions

Transient dose of rapamycin in middle age can increase life expectancy, improve measures of healthy aging

Scientists move a step closer to translating BubR1 protein's function into potential cancer therapy

MDI Biological Laboratory researchers receive patent for novel heart disease drug

Novel scaffolds may open new avenues in stem and cancer cell manipulation

New drug target could help prevent opioid tolerance and addiction

Injecting omega-3 fatty acid reduces brain damage in neonatal mouse model of stroke

Genekam develops first therapeutic molecule candidate for Zika viruses

Vertebroplasty helps decrease acute pain in patients with osteoporotic fractures

Checkpoint inhibitor for treatment of NSCLC patients shows indication of added benefit

Added benefit of combination drug for HIV-infected patients not proven

Smokers who switch to vaping may have fewer respiratory infections, study reveals

Added benefit of lung cancer drug not proven, says IQWiG

Added benefit not proven for orphan drug in treatment of adults with stomach cancer

Added benefit still not proven for epilepsy drug

Penn researchers uncover strategy to reverse effects of dyskeratosis congenita

Cell therapy product can accelerate brain remyelination in mice

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News